Page last updated: 2024-08-17

carbostyril and Cortical Lewy Body Disease

carbostyril has been researched along with Cortical Lewy Body Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwankhaus, J; Singh, S1
Hurtig, HI; Weintraub, D1

Reviews

1 review(s) available for carbostyril and Cortical Lewy Body Disease

ArticleYear
Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
    The American journal of psychiatry, 2007, Volume: 164, Issue:10

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Cholinesterase Inhibitors; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Humans; Lewy Body Disease; Male; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones

2007

Other Studies

1 other study(ies) available for carbostyril and Cortical Lewy Body Disease

ArticleYear
Olfactory disturbance in Parkinson disease.
    Archives of neurology, 2009, Volume: 66, Issue:6

    Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; Cognition Disorders; Constipation; Diagnosis, Differential; Disease Progression; Electroencephalography; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Male; Olfactory Pathways; Parkinson Disease; Piperazines; Piracetam; Quinolones; REM Sleep Behavior Disorder; Treatment Failure; Tremor

2009